A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity

Summary

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07976016) for the potential treatment of obesity. The study will compare the experiences of participants taking the study medicine (PF-07976016) to those of participants who take placebo (a lookalike substance that contains no active study medicine). The aim is to measure the body's response to the study medicine, including any changes in participants' body weight and how well they tolerate the study medicine.

Timeline

Start

2024-12-09

Primary completion

2025-10-23

Completion

2026-01-12

Drugs

Indications